Odoribacter laneus DSM 22474 is an anaerobe, mesophilic, Gram-negative prokaryote that was isolated from human faeces of healthy Japanese adult.
Gram-negative rod-shaped anaerobe mesophilic genome sequence 16S sequence| @ref 20215 |
|
Last LPSN update
2026-02-09 11:20:51 |
| Domain Bacteria |
| Phylum Bacteroidota |
| Class Bacteroidia |
| Order Bacteroidales |
| Family Odoribacteraceae |
| Genus Odoribacter |
| Species Odoribacter laneus |
| Full scientific name Odoribacter laneus Nagai et al. 2010 |
| @ref | Name | Growth | Medium link | Composition | |
|---|---|---|---|---|---|
| 16357 | FASTIDIOUS ANAEROBE BROTH (DSMZ Medium 1203a) | Medium recipe at MediaDive  | Name: FASTIDIOUS ANAEROBE BROTH (DSMZ Medium 1203a) Composition: Fastidious Anaerobe Basal Broth 35.4 g/l Distilled water | ||
| 16357 | PYG MEDIUM (MODIFIED) (DSMZ Medium 104) | Medium recipe at MediaDive | Name: PYG MEDIUM (modified) (DSMZ Medium 104) Composition: Yeast extract 10.0 g/l Peptone 5.0 g/l Trypticase peptone 5.0 g/l Beef extract 5.0 g/l Glucose 5.0 g/l L-Cysteine HCl x H2O 0.5 g/l NaHCO3 0.4 g/l NaCl 0.08 g/l K2HPO4 0.04 g/l KH2PO4 0.04 g/l MgSO4 x 7 H2O 0.02 g/l CaCl2 x 2 H2O 0.01 g/l Hemin 0.005 g/l Ethanol 0.0038 g/l Resazurin 0.001 g/l Tween 80 Vitamin K1 NaOH Distilled water | ||
| 16357 | COLUMBIA BLOOD MEDIUM (DSMZ Medium 693) | Medium recipe at MediaDive | Name: COLUMBIA BLOOD MEDIUM (DSMZ Medium 693) Composition: Defibrinated sheep blood 50.0 g/l Columbia agar base |
| @ref | Chebi-ID | Metabolite | Utilization activity | Kind of utilization tested | |
|---|---|---|---|---|---|
| 68380 | 29016 ChEBI | arginine | - | hydrolysis | from API rID32A |
| 68367 | 17057 ChEBI | cellobiose | - | builds acid from | from API 20A |
| 68367 | 17634 ChEBI | D-glucose | - | builds acid from | from API 20A |
| 68367 | 16899 ChEBI | D-mannitol | - | builds acid from | from API 20A |
| 68380 | 16024 ChEBI | D-mannose | - | fermentation | from API rID32A |
| 68367 | 16024 ChEBI | D-mannose | - | builds acid from | from API 20A |
| 68367 | 65327 ChEBI | D-xylose | - | builds acid from | from API 20A |
| 68367 | 4853 ChEBI | esculin | - | hydrolysis | from API 20A |
| 68367 | 5291 ChEBI | gelatin | + | hydrolysis | from API 20A |
| 68367 | 17754 ChEBI | glycerol | - | builds acid from | from API 20A |
| 68367 | 30849 ChEBI | L-arabinose | - | builds acid from | from API 20A |
| 68380 | 29985 ChEBI | L-glutamate | - | degradation | from API rID32A |
| 68367 | 62345 ChEBI | L-rhamnose | - | builds acid from | from API 20A |
| 68367 | 17716 ChEBI | lactose | - | builds acid from | from API 20A |
| 68367 | 17306 ChEBI | maltose | - | builds acid from | from API 20A |
| 68367 | 6731 ChEBI | melezitose | - | builds acid from | from API 20A |
| 68380 | 17632 ChEBI | nitrate | - | reduction | from API rID32A |
| 68380 | 16634 ChEBI | raffinose | - | fermentation | from API rID32A |
| 68367 | 16634 ChEBI | raffinose | - | builds acid from | from API 20A |
| 68367 | 17814 ChEBI | salicin | - | builds acid from | from API 20A |
| 68367 | 30911 ChEBI | sorbitol | - | builds acid from | from API 20A |
| 68367 | 17992 ChEBI | sucrose | - | builds acid from | from API 20A |
| 68367 | 27082 ChEBI | trehalose | - | builds acid from | from API 20A |
| 68380 | 27897 ChEBI | tryptophan | + | energy source | from API rID32A |
| 68367 | 27897 ChEBI | tryptophan | + | energy source | from API 20A |
| 68380 | 16199 ChEBI | urea | - | hydrolysis | from API rID32A |
| 68367 | 16199 ChEBI | urea | - | hydrolysis | from API 20A |
| @ref | Value | Activity | Ec | |
|---|---|---|---|---|
| 29508 | acid phosphatase | + | 3.1.3.2 | |
| 68380 | alanine arylamidase | + | 3.4.11.2 | from API rID32A |
| 29508 | alkaline phosphatase | + | 3.1.3.1 | |
| 68380 | alkaline phosphatase | + | 3.1.3.1 | from API rID32A |
| 68380 | alpha-arabinosidase | - | 3.2.1.55 | from API rID32A |
| 29508 | alpha-galactosidase | + | 3.2.1.22 | |
| 68380 | alpha-galactosidase | + | 3.2.1.22 | from API rID32A |
| 68380 | alpha-glucosidase | + | 3.2.1.20 | from API rID32A |
| 68380 | arginine dihydrolase | - | 3.5.3.6 | from API rID32A |
| 68380 | beta-galactosidase | + | 3.2.1.23 | from API rID32A |
| 68380 | beta-glucosidase | - | 3.2.1.21 | from API rID32A |
| 68367 | beta-glucosidase | - | 3.2.1.21 | from API 20A |
| 68380 | beta-glucuronidase | - | 3.2.1.31 | from API rID32A |
| 29508 | gelatinase | + | ||
| 68367 | gelatinase | + | from API 20A | |
| 68380 | glutamate decarboxylase | - | 4.1.1.15 | from API rID32A |
| 68380 | glutamyl-glutamate arylamidase | - | from API rID32A | |
| 68380 | glycin arylamidase | - | from API rID32A | |
| 68380 | histidine arylamidase | - | from API rID32A | |
| 68380 | leucyl glycin arylamidase | + | 3.4.11.1 | from API rID32A |
| 68380 | N-acetyl-beta-glucosaminidase | + | 3.2.1.52 | from API rID32A |
| 68380 | phenylalanine arylamidase | - | from API rID32A | |
| 68380 | proline-arylamidase | - | 3.4.11.5 | from API rID32A |
| 68380 | pyrrolidonyl arylamidase | - | 3.4.19.3 | from API rID32A |
| 68380 | serine arylamidase | - | from API rID32A | |
| 68380 | tryptophan deaminase | + | 4.1.99.1 | from API rID32A |
| 68380 | tyrosine arylamidase | - | from API rID32A | |
| 68380 | urease | - | 3.5.1.5 | from API rID32A |
| 68367 | urease | - | 3.5.1.5 | from API 20A |
| @ref | IND | URE | GLU | MAN | LAC | SAC | MAL | SAL | XYL | ARA | GEL | ESC | GLY | CEL | MNE | MLZ | RAF | SOR | RHA | TRE | CAT | Spores presentSPOR | GramGRAM | Morphology coccus="+" rod="-"COCC | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 16357 | + | - | - | - | - | - | - | - | - | - | + | - | - | - | - | - | - | - | - | - | not determinedn.d. | not determinedn.d. | not determinedn.d. | not determinedn.d. |
| Cat1 | Cat2 | Cat3 | |
|---|---|---|---|
| #Host | #Human | - | |
| #Host Body Product | #Gastrointestinal tract | #Feces (Stool) |
Global distribution of 16S sequence AB547648 (>99% sequence identity) for Odoribacter laneus subclade from Microbeatlas 
 Aquatic Samples |
1394 |
 Soil Samples |
190 |
 Animal Samples |
21002 |
 Plant Samples |
34 |
| Total Samples | 22620 |
| @ref | Description | Assembly level | INSDC accession | BV-BRC accession | IMG accession | NCBI tax ID | Score | |
|---|---|---|---|---|---|---|---|---|
| 66792 | Odor_lane_YIT_12061_V1 assembly for Odoribacter laneus YIT 12061 | scaffold | GCA_000243215   | 742817.3  | 2513237280  | 742817 | 70.08 | |
| Topic | Title | Authors | Journal | DOI | Year | |
|---|---|---|---|---|---|---|
| Pathogenicity | Orally administered Odoribacter laneus improves glucose control and inflammatory profile in obese mice by depleting circulating succinate. | Huber-Ruano I, Calvo E, Mayneris-Perxachs J, Rodriguez-Pena MM, Ceperuelo-Mallafre V, Cedo L, Nunez-Roa C, Miro-Blanch J, Arnoriaga-Rodriguez M, Balvay A, Maudet C, Garcia-Roves P, Yanes O, Rabot S, Grimaud GM, De Prisco A, Amoruso A, Fernandez-Real JM, Vendrell J, Fernandez-Veledo S. | Microbiome | 10.1186/s40168-022-01306-y | 2022 | |
| High-Resolution Taxonomic Characterization Reveals Novel Human Microbial Strains with Potential as Risk Factors and Probiotics for Prediabetes and Type 2 Diabetes. | Hendricks SA, Vella CA, New DD, Aunjum A, Antush M, Geidl R, Andrews KR, Balemba OB. | Microorganisms | 10.3390/microorganisms11030758 | 2023 | | |
| Metabolism | A bacterial bile acid metabolite modulates Treg activity through the nuclear hormone receptor NR4A1. | Li W, Hang S, Fang Y, Bae S, Zhang Y, Zhang M, Wang G, McCurry MD, Bae M, Paik D, Franzosa EA, Rastinejad F, Huttenhower C, Yao L, Devlin AS, Huh JR. | Cell Host Microbe | 10.1016/j.chom.2021.07.013 | 2021 | |
| Exploring bacterial metabolites in microbe-human host dialogue and their therapeutic potential in Alzheimer's diseases. | Singh SD, Bharali P, Nagamani S. | Mol Divers | 10.1007/s11030-024-11028-y | 2025 | | |
| A consortium of Hordeum vulgare and gut microbiota against non-alcoholic fatty liver disease via data-driven analysis. | Lee SB, Gupta H, Min BH, Ganesan R, Sharma SP, Won SM, Jeong JJ, Cha MG, Kwon GH, Jeong MK, Hyun JY, Eom JA, Park HJ, Yoon SJ, Lee SY, Choi MR, Kim DJ, Oh KK, Suk KT. | Artif Cells Nanomed Biotechnol | 10.1080/21691401.2024.2347380 | 2024 | | |
| Gut microbiome in association with chemotherapy-induced toxicities among patients with breast cancer. | Nguyen SM, Tran HTT, Long J, Shrubsole MJ, Cai H, Yang Y, Cai Q, Tran TV, Zheng W, Shu XO. | Cancer | 10.1002/cncr.35229 | 2024 | | |
| Gut-disc axis: A Mendelian randomization study on the relationship between gut microbiota and cervical spondylosis. | Zhang J, Wang B, Du P, Song H, Yang L, Zhou Y. | Medicine (Baltimore) | 10.1097/md.0000000000041536 | 2025 | | |
| Metabolism | Metabolic and transcriptional effects of bazedoxifene/conjugated estrogens in a model of obesity-associated breast cancer risk. | Giles ED, Cook KL, Jenschke RM, Corleto KA, Landrock D, Mahmood TN, Sanchez KE, Levin A, Hursting SD, Kimler BF, Komm BS, Fabian CJ. | JCI Insight | 10.1172/jci.insight.182694 | 2025 | |
| Genetics | Genetically predicted blood metabolites mediate relationships between gut microbiota and ovarian cancer: a Mendelian randomization study. | Zhang L, Cao T, Liu K, Sun P, Wang W, Guo J. | Front Cell Infect Microbiol | 10.3389/fcimb.2024.1451880 | 2024 | |
| Pathogenicity | 2,5-dimethylcelecoxib alleviated NK and T-cell exhaustion in hepatocellular carcinoma via the gastrointestinal microbiota-AMPK-mTOR axis. | Pan B, Chen Z, Zhang X, Wang Z, Yao Y, Wu X, Qiu J, Lin H, Yu L, Tu H, Tang N. | J Immunother Cancer | 10.1136/jitc-2023-006817 | 2023 | |
| Circulating Inflammatory Proteins Mediate the Causal Effect of Gut Microbiota on Inflammatory Bowel Disease: Bayesian and Mediated Mendelian Randomization. | Li Z, Jia L, Huai S. | FASEB Bioadv | 10.1096/fba.2025-00114 | 2025 | | |
| The Role of Next-Generation Probiotics in Obesity and Obesity-Associated Disorders: Current Knowledge and Future Perspectives. | Vallianou NG, Kounatidis D, Tsilingiris D, Panagopoulos F, Christodoulatos GS, Evangelopoulos A, Karampela I, Dalamaga M. | Int J Mol Sci | 10.3390/ijms24076755 | 2023 | | |
| Sturgeon-derived peptide LLLE alleviates colitis via regulating gut microbiota and its metabolites. | Lin J, Yang J, Cui L, Nagpal R, Singh P, Salazar G, Rao Q, Peng Y, Sun Q. | Curr Res Food Sci | 10.1016/j.crfs.2024.100898 | 2024 | | |
| Gut commensal bacterium Bacteroides vulgatus exacerbates helminth-induced cardiac fibrosis through succinate accumulation. | Wang J, Yin J, Liu X, Liu Y, Jin X. | PLoS Pathog | 10.1371/journal.ppat.1013069 | 2025 | | |
| Nutritional Interventions with Bacillus coagulans Improved Glucose Metabolism and Hyperinsulinemia in Mice with Acute Intermittent Porphyria. | Longo M, Jerico D, Cordoba KM, Riezu-Boj JI, Urtasun R, Solares I, Sampedro A, Collantes M, Penuelas I, Moreno-Aliaga MJ, Avila MA, Di Pierro E, Barajas M, Milagro FI, Dongiovanni P, Fontanellas A. | Int J Mol Sci | 10.3390/ijms241511938 | 2023 | | |
| Research status and development trends of probiotics in clinical applications. | Li Y, Yao Y, Zhang Z, Gan Y. | Front Nutr | 10.3389/fnut.2025.1650883 | 2025 | | |
| Assessment of Auricularia cornea var. Li. polysaccharides potential to improve hepatic, antioxidation and intestinal microecology in rats with non-alcoholic fatty liver disease. | Zhou T, Mao X, Jiang W, Pan Y, Chen X, Hu J, Kong X, Xia H. | Front Nutr | 10.3389/fnut.2023.1161537 | 2023 | | |
| Gut microbiota mediates the pro-pyroptosis effect of xierezhuyubuxu decoction in hepatocellular carcinoma. | Zeng Z, Feng M, He F, Zhang E, Li X, Cao Z. | Front Microbiol | 10.3389/fmicb.2024.1481111 | 2024 | | |
| Unveiling the connection between gut microbiome and metabolic health in individuals with chronic spinal cord injury. | Li J, Barnes S, Lefkowitz E, Yarar-Fisher C. | Physiol Genomics | 10.1152/physiolgenomics.00107.2023 | 2024 | | |
| Association between Gut Microbiota Dysbiosis and the CHA2DS2-VASc Score in Atrial Fibrillation Patients. | Fang C, Zuo K, Zhang W, Zhong J, Li J, Xu L, Yang X. | Int J Clin Pract | 10.1155/2022/7942605 | 2022 | | |
| Phylogeny | Fecal Microbiome Characteristics and the Resistome Associated With Acquisition of Multidrug-Resistant Organisms Among Elderly Subjects. | Araos R, Battaglia T, Ugalde JA, Rojas-Herrera M, Blaser MJ, D'Agata EMC. | Front Microbiol | 10.3389/fmicb.2019.02260 | 2019 | |
| Pathogenicity | Phenotyping of Fecal Microbiota of Winnie, a Rodent Model of Spontaneous Chronic Colitis, Reveals Specific Metabolic, Genotoxic, and Pro-inflammatory Properties. | Tala A, Guerra F, Resta SC, Calcagnile M, Barca A, Tredici SM, De Donno MD, Vacca M, Liso M, Chieppa M, De Angelis M, Verri T, Bozzetti MG, Bucci C, Alifano P. | Inflammation | 10.1007/s10753-022-01706-0 | 2022 | |
| Pathogenicity | Microbial-Based Bioactive Compounds to Alleviate Inflammation in Obesity. | Apalowo OE, Adegoye GA, Obuotor TM. | Curr Issues Mol Biol | 10.3390/cimb46030119 | 2024 | |
| Analysis of Genetic and MRI Changes, Blood Markers, and Risk Factors in a Twin Pair Discordant of Progressive Supranuclear Palsy. | Persely A, Beszedics B, Paloczi K, Piroska M, Alijanpourotaghsara A, Strelnikov D, Vessal A, Szabo H, Hernyes A, Zoldi L, Jokkel Z, Fekete A, Juhasz J, Makra N, Szabo D, Buzas E, Tarnoki AD, Tarnoki DL. | Medicina (Kaunas) | 10.3390/medicina59101696 | 2023 | | |
| Type 2 diabetes and succinate: unmasking an age-old molecule. | Fernandez-Veledo S, Marsal-Beltran A, Vendrell J. | Diabetologia | 10.1007/s00125-023-06063-7 | 2024 | | |
| Sishen Pill and its active phytochemicals in treating inflammatory bowel disease and colon cancer: an overview. | Zhang B, Cheng Y, Jian Q, Xiang S, Xu Q, Wang C, Yang C, Lin J, Zheng C. | Front Pharmacol | 10.3389/fphar.2024.1375585 | 2024 | | |
| Exploring the Relationship between the Gut Microbiota and Ageing: A Possible Age Modulator. | Salazar J, Duran P, Diaz MP, Chacin M, Santeliz R, Mengual E, Gutierrez E, Leon X, Diaz A, Bernal M, Escalona D, Hernandez LAP, Bermudez V. | Int J Environ Res Public Health | 10.3390/ijerph20105845 | 2023 | | |
| specificity: an R package for analysis of feature specificity to environmental and higher dimensional variables, applied to microbiome species data. | Darcy JL, Amend AS, Swift SOI, Sommers PS, Lozupone CA. | Environ Microbiome | 10.1186/s40793-022-00426-0 | 2022 | | |
| Prebiotic proanthocyanidins inhibit bile reflux-induced esophageal adenocarcinoma through reshaping the gut microbiome and esophageal metabolome. | Weh KM, Howard CL, Zhang Y, Tripp BA, Clarke JL, Howell AB, Rubenstein JH, Abrams JA, Westerhoff M, Kresty LA. | JCI Insight | 10.1172/jci.insight.168112 | 2024 | | |
| Insights into the gut-liver axis: mechanisms and emerging therapies in hepatocellular carcinoma | Hu Y, Gao M, Chenghuang J, Bao R. | Front Pharmacol | 2025 | | ||
| Analyses of Lipid A Diversity in Gram-Negative Intestinal Bacteria Using Liquid Chromatography-Quadrupole Time-of-Flight Mass Spectrometry. | Okahashi N, Ueda M, Matsuda F, Arita M. | Metabolites | 10.3390/metabo11040197 | 2021 | | |
| Zinc Deficiency During Pregnancy Leads to Altered Microbiome and Elevated Inflammatory Markers in Mice. | Sauer AK, Grabrucker AM. | Front Neurosci | 10.3389/fnins.2019.01295 | 2019 | | |
| Enzymology | The high prevalence of Clostridioides difficile among nursing home elders associates with a dysbiotic microbiome. | Haran JP, Ward DV, Bhattarai SK, Loew E, Dutta P, Higgins A, McCormick BA, Bucci V. | Gut Microbes | 10.1080/19490976.2021.1897209 | 2021 | |
| Pathogenicity | Eubacterium rectale Attenuates HSV-1 Induced Systemic Inflammation in Mice by Inhibiting CD83. | Islam SMS, Ryu HM, Sayeed HM, Byun HO, Jung JY, Kim HA, Suh CH, Sohn S. | Front Immunol | 10.3389/fimmu.2021.712312 | 2021 | |
| Genetics | Longitudinal fecal microbiome and metabolite data demonstrate rapid shifts and subsequent stabilization after an abrupt dietary change in healthy adult dogs. | Lin CY, Jha AR, Oba PM, Yotis SM, Shmalberg J, Honaker RW, Swanson KS. | Anim Microbiome | 10.1186/s42523-022-00194-9 | 2022 | |
| Variation of Carbohydrate-Active Enzyme Patterns in the Gut Microbiota of Italian Healthy Subjects and Type 2 Diabetes Patients. | Soverini M, Turroni S, Biagi E, Quercia S, Brigidi P, Candela M, Rampelli S. | Front Microbiol | 10.3389/fmicb.2017.02079 | 2017 | | |
| Genetics | Bacterial community structure alterations within the colorectal cancer gut microbiome. | Loftus M, Hassouneh SA, Yooseph S. | BMC Microbiol | 10.1186/s12866-021-02153-x | 2021 | |
| Effects of Dietary Antimicrobial Growth Promoters on Performance Parameters and Abundance and Diversity of Broiler Chicken Gut Microbiome and Selection of Antibiotic Resistance Genes. | Paul SS, Rama Rao SV, Hegde N, Williams NJ, Chatterjee RN, Raju MVLN, Reddy GN, Kumar V, Phani Kumar PS, Mallick S, Gargi M. | Front Microbiol | 10.3389/fmicb.2022.905050 | 2022 | | |
| Pathogenicity | Novel Odoribacter splanchnicus Strain and Its Outer Membrane Vesicles Exert Immunoregulatory Effects in vitro. | Hiippala K, Barreto G, Burrello C, Diaz-Basabe A, Suutarinen M, Kainulainen V, Bowers JR, Lemmer D, Engelthaler DM, Eklund KK, Facciotti F, Satokari R. | Front Microbiol | 10.3389/fmicb.2020.575455 | 2020 | |
| Metabolism | The Antimicrobial Peptide CRAMP Is Essential for Colon Homeostasis by Maintaining Microbiota Balance. | Yoshimura T, McLean MH, Dzutsev AK, Yao X, Chen K, Huang J, Gong W, Zhou J, Xiang Y, H Badger J, O'hUigin C, Thovarai V, Tessarollo L, Durum SK, Trinchieri G, Bian XW, Wang JM. | J Immunol | 10.4049/jimmunol.1602073 | 2018 | |
| Permissive microbiome characterizes human subjects with a neurovascular disease cavernous angioma. | Polster SP, Sharma A, Tanes C, Tang AT, Mericko P, Cao Y, Carrion-Penagos J, Girard R, Koskimaki J, Zhang D, Stadnik A, Romanos SG, Lyne SB, Shenkar R, Yan K, Lee C, Akers A, Morrison L, Robinson M, Zafar A, Bittinger K, Kim H, Gilbert JA, Kahn ML, Shen L, Awad IA. | Nat Commun | 10.1038/s41467-020-16436-w | 2020 | | |
| Metabolism | Microbiota regulate innate immune signaling and protective immunity against cancer. | Xing C, Wang M, Ajibade AA, Tan P, Fu C, Chen L, Zhu M, Hao ZZ, Chu J, Yu X, Yin B, Zhu J, Shen WJ, Duan T, Wang HY, Wang RF. | Cell Host Microbe | 10.1016/j.chom.2021.03.016 | 2021 | |
| Genetics | Dispersal strategies shape persistence and evolution of human gut bacteria. | Hildebrand F, Gossmann TI, Frioux C, Ozkurt E, Myers PN, Ferretti P, Kuhn M, Bahram M, Nielsen HB, Bork P. | Cell Host Microbe | 10.1016/j.chom.2021.05.008 | 2021 | |
| Metagenomic identification of a novel salt tolerance gene from the human gut microbiome which encodes a membrane protein with homology to a brp/blh-family beta-carotene 15,15'-monooxygenase. | Culligan EP, Sleator RD, Marchesi JR, Hill C. | PLoS One | 10.1371/journal.pone.0103318 | 2014 | | |
| Phylogeny | Genome-Based Taxonomic Classification of Bacteroidetes. | Hahnke RL, Meier-Kolthoff JP, Garcia-Lopez M, Mukherjee S, Huntemann M, Ivanova NN, Woyke T, Kyrpides NC, Klenk HP, Goker M. | Front Microbiol | 10.3389/fmicb.2016.02003 | 2016 | |
| Genetics | Analysis of 1,000 Type-Strain Genomes Improves Taxonomic Classification of Bacteroidetes. | Garcia-Lopez M, Meier-Kolthoff JP, Tindall BJ, Gronow S, Woyke T, Kyrpides NC, Hahnke RL, Goker M. | Front Microbiol | 10.3389/fmicb.2019.02083 | 2019 | |
| Characterization and description of Gabonibacter chumensis sp. nov., isolated from feces of a patient with non-small cell lung cancer treated with immunotherapy. | Diop K, Pidgeon R, Diop A, Benlaifaoui M, Belkaid W, Malo J, Bernet E, Veyrier F, Jacq M, Brun Y, Elkrief A, Castagner B, Routy B, Richard C. | Arch Microbiol | 10.1007/s00203-023-03671-0 | 2023 | | |
| Taxonogenomics of Culturomica massiliensis gen. nov., sp. nov., and Emergencia timonensis gen. nov., sp. nov. new bacteria isolated from human stool microbiota. | Hamame A, Magdy Wasfy R, Lo CI, Fenollar F, Raoult D, Fournier PE, Houhamdi L. | Sci Rep | 10.1038/s41598-023-35443-7 | 2023 | | |
| Genetics | Butyricimonas phoceensis sp. nov., a new anaerobic species isolated from the human gut microbiota of a French morbidly obese patient. | Togo AH, Diop A, Dubourg G, Nguyen TT, Andrieu C, Caputo A, Couderc C, Fournier PE, Maraninchi M, Valero R, Raoult D, Million M. | New Microbes New Infect | 10.1016/j.nmni.2016.07.010 | 2016 | |
| Phylogeny | Alistipes indistinctus sp. nov. and Odoribacter laneus sp. nov., common members of the human intestinal microbiota isolated from faeces. | Nagai F, Morotomi M, Watanabe Y, Sakon H, Tanaka R | Int J Syst Evol Microbiol | 10.1099/ijs.0.014571-0 | 2009 | |
How to citeIf you want to cite this particular strain cite the following doi:
https://doi.org/10.13145/bacdive12521.20251217.10
When using BacDive for research please cite the following paper
BacDive in 2025: the core database for prokaryotic strain data
License